Pages

▼
Monday, December 23, 2019

Where is the news?

›
December 23, 2019 My first Day in the Hospital ! I AM SENDING MY APOLOGIES TO YOU! I just returned after 14 days from the hospit...
15 comments:
Saturday, December 7, 2019

Understanding What Parkinson’s Progression Means to Each Patient

›
DECEMBER 6, 2019 BY DR. C Every day following the  ruin of stagnation , it seems that I have progressed from early Parkinson’s to a...
10 comments:

Dosing Begins in Phase 2 Trial of CNM-Au8, Potential Therapy for Dopaminergic Neurons

›
DECEMBER 6, 2019   BY PATRICIA INACIO, PHD A pilot Phase 2 study evaluating  CNM-Au8 , an investigational  Parkinson’s  treatment a...
10 comments:
Thursday, December 5, 2019

Exploring the Diversity of Parkinson's Proteins

›
Dec 05, 2019   Original story from the German Center for Neurodegenerative Diseases Parkinson’s and multisystem atrophy (MSA) – bo...
9 comments:

Patent Describes Apple Watch Feature for Improving Treatment of Parkinson's Disease Symptoms

›
December 5, 2019  by Tim Hardwick (Rumors) A newly unearthed patent reveals that Apple is exploring how a future  Apple Watch  could help...
3 comments:

Scientists identify chaperones as potential therapies for Parkinson's disease

›
 December 5, 2019       By Samantha Black, Ph.D.   University of Basel, Biozentrum Researchers from the University of Basel hav...
4 comments:

Drug helped dementia patients curb their hallucinations and delusions

›
December 5, 2019 Nuplazid, a drug that treats psychosis in patients with Parkinson’s disease, also curbed hallucinations and delusions ...
4 comments:

Parkinson’s Changes the Rules: It’s OK to Ask for Help

›
DECEMBER 5, 2019 By  Lori DePorter We all have a fundamental desire to help our loved ones, and this is particularly true of those ...
3 comments:

Exposure to Second-Hand Smoke Linked to Lower Risk of Developing Parkinson’s, Study Suggests

›
DECEMBER 5, 2019 BY CATARINA SILVA, MSC Second-hand smoke  may have a neuroprotective effect, as exposure to this type of indoor p...
11 comments:

Aphios Granted US Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases

›
December 05, 2019 WOBURN, Mass.--( BUSINESS WIRE )--Aphios Corporation today announced that it was granted United States Patent...
1 comment: